![](/img/cover-not-exists.png)
A phase Ib study of entinostat plus lapatinib with or without trastuzumab in patients with HER2-positive metastatic breast cancer that progressed during trastuzumab treatment
Lim, Bora, Murthy, Rashmi K., Lee, Jangsoon, Jackson, Summer A., Iwase, Toshiaki, Davis, Darren W., Willey, Jie S., Wu, Jimin, Shen, Yu, Tripathy, Debu, Alvarez, Ricardo, Ibrahim, Nuhad K., Brewster,Language:
english
Journal:
British Journal of Cancer
DOI:
10.1038/s41416-019-0473-y
Date:
May, 2019
File:
PDF, 507 KB
english, 2019